Literature DB >> 26846421

Multisubstance Use Among Treatment-Seeking Smokers: Synergistic Effects of Coping Motives for Cannabis and Alcohol Use and Social Anxiety/Depressive Symptoms.

Dawn W Foster1, Julia D Buckner2, Norman B Schmidt3, Michael J Zvolensky4,5.   

Abstract

OBJECTIVE: This study examined the impact of coping motives for cannabis and alcohol use on the relation between social anxiety/depressive symptoms and severity of substance use for alcohol, tobacco, and cannabis among treatment-seeking smokers who also use cannabis and alcohol.
METHODS: The sample included 197 daily cigarette smokers (MAge 34.81 years, SD = 13.43) who reported using cannabis and alcohol.
RESULTS: Hierarchical multiple regression analyses were conducted wherein separate models were constructed for each dependent variable. Among individuals with higher social anxiety, alcohol coping motives were associated with heavier drinking, and this was more pronounced among those low in depressive symptoms. Similarly, those at greater risk for nicotine dependence were anxious individuals with lower depressive symptoms who endorse coping-oriented motives for using cannabis. Further, among those with higher social anxiety, cannabis coping motives were associated with marginally greater drinking, particularly for those high in depressive symptoms.
CONCLUSIONS: The present findings support the perspective that among multisubstance users, the interplay between social anxiety, depressive symptoms, and coping-oriented motives for using one substance (e.g., cannabis or alcohol) may pose difficulties in refraining from other substances (e.g., tobacco). This observation highlights the importance of tailoring multisubstance treatments to specific needs of multiusers for whom single-substance interventions may be less effective. Findings also support previous work exploring the benefits of concurrently treating co-occurring substance use and lend credence to the perspective that motivation to use substances for coping reasons is of central theoretical and clinical relevance.

Entities:  

Keywords:  Coping; alcohol; cannabis; depressive symptoms; motives; social anxiety; tobacco

Mesh:

Year:  2016        PMID: 26846421      PMCID: PMC4755824          DOI: 10.3109/10826084.2015.1082596

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  76 in total

1.  A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68).

Authors:  Megan E Piper; Thomas M Piasecki; E Belle Federman; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2004-04

2.  Marijuana-related problems and social anxiety: the role of marijuana behaviors in social situations.

Authors:  Julia D Buckner; Richard G Heimberg; Russell A Matthews; Jose Silgado
Journal:  Psychol Addict Behav       Date:  2011-10-17

3.  Tobacco smoking: a comparison between alcohol and drug abuse inpatients.

Authors:  T A Burling; D C Ziff
Journal:  Addict Behav       Date:  1988       Impact factor: 3.913

4.  Coping motives as a moderator of daily mood-drinking covariation.

Authors:  Andrea M Hussong; Christopher A Galloway; Laura A Feagans
Journal:  J Stud Alcohol       Date:  2005-05

5.  Alcohol and tension reduction: cognitive and physiological effects.

Authors:  J Polivy; A L Schueneman; K Carlson
Journal:  J Abnorm Psychol       Date:  1976-12

6.  Depressive symptoms and the implicit evaluation of alcohol: the moderating role of coping motives.

Authors:  Timothy E Ralston; Tibor P Palfai
Journal:  Drug Alcohol Depend       Date:  2011-10-02       Impact factor: 4.492

7.  Social anxiety and marijuana-related problems: the role of social avoidance.

Authors:  Julia D Buckner; Richard G Heimberg; Norman B Schmidt
Journal:  Addict Behav       Date:  2010-08-25       Impact factor: 3.913

8.  Drink refusal self-efficacy and implicit drinking identity: an evaluation of moderators of the relationship between self-awareness and drinking behavior.

Authors:  Dawn W Foster; Clayton Neighbors; Chelsie M Young
Journal:  Addict Behav       Date:  2013-10-02       Impact factor: 3.913

9.  Smoking and social anxiety: the roles of gender and smoking motives.

Authors:  Julia D Buckner; Christine Vinci
Journal:  Addict Behav       Date:  2013-03-21       Impact factor: 3.913

10.  The alcohol use disorders identification test (AUDIT) in a college sample.

Authors:  M F Fleming; K L Barry; R MacDonald
Journal:  Int J Addict       Date:  1991-11
View more
  5 in total

1.  The Relationship Between Social Anxiety and Alcohol and Marijuana Use Outcomes Among Concurrent Users: A Motivational Model of Substance Use.

Authors:  Margo C Villarosa-Hurlocker; Adrian J Bravo; Matthew R Pearson
Journal:  Alcohol Clin Exp Res       Date:  2019-03-04       Impact factor: 3.455

2.  A developmental-based motivational intervention to reduce alcohol and marijuana use among non-treatment-seeking young adults: a randomized controlled trial.

Authors:  Michael D Stein; Celeste M Caviness; Emily F Morse; Kristin R Grimone; Daniel Audet; Debra S Herman; Ethan Moitra; Bradley J Anderson
Journal:  Addiction       Date:  2017-10-16       Impact factor: 6.526

3.  A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors:  Stefania Chiappini; Fabrizio Schifano
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

4.  Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada.

Authors:  Nibene H Somé; Mostafa Shokoohi; Kevin D Shield; Samantha Wells; Hayley A Hamilton; Tara Elton-Marshall; Alex Abramovich
Journal:  BMC Public Health       Date:  2022-03-07       Impact factor: 3.295

5.  Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis.

Authors:  Nibene Habib Somé; Samantha Wells; Daniel Felsky; Hayley A Hamilton; Shehzad Ali; Tara Elton-Marshall; Jürgen Rehm
Journal:  BMC Psychiatry       Date:  2022-04-30       Impact factor: 4.144

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.